TAIPEI, TAIWAN / SINGAPORE – November 25th, 2020 – iXensor Co., Ltd. (6734.TWO) Backed by two pharmaceutical giants Roche, Sanofi and organized by Plug and Play, the Startup Creasphere Program selected iXensor to join its three-month digital health accelerator program, which aimed for transforming healthcare together. In this first…
iXensor expedites the remote co-development of Deficiency of Adenosine Deaminase 2 rapid test at DADA2 conference
At the 3rd International Conference on Deficiency of Adenosine Deaminase 2 (DADA2), the CEO of iXensor, Dr. Carson Chen, speaks about XLab and its applications in realizing remote collaboration of developing accessible and affordable DADA2 diagnostic test with test strip developers across the globe. Dr. Carson Chen encountered the CEO…
iXensor gears up to launch the PixoTest® COVID-19 Antigen Test and PixoHealth Pass
PixoTest® is among the fastest COVID-19 antigen tests for smarter pandemic management, detecting positive SARS-CoV-2 infection cases in as short as five minutes. The PixoTest® POCT Analyzer offers prompt, accurate, and objective results through the standardized analysis of the rapid tests. PixoHealth Pass App is positioned as the digital screening tool…